119 related articles for article (PubMed ID: 36332805)
1. Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease.
Hagström H; Thiele M; Sharma R; Simon TG; Roelstraete B; Söderling J; Sundström J; Ludvigsson JF
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1841-1853.e12. PubMed ID: 36332805
[TBL] [Abstract][Full Text] [Related]
2. Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 Persons.
Hagström H; Thiele M; Sharma R; Simon TG; Roelstraete B; Söderling J; Ludvigsson JF
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):918-929.e8. PubMed ID: 33421629
[TBL] [Abstract][Full Text] [Related]
3. Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease.
Hagström H; Thiele M; Simon TG; Sharma R; Röckert Tjernberg A; Roelstraete B; Söderling J; Ludvigsson JF
United European Gastroenterol J; 2022 Mar; 10(2):198-211. PubMed ID: 35088575
[TBL] [Abstract][Full Text] [Related]
4. Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients.
Hagström H; Thiele M; Roelstraete B; Söderling J; Ludvigsson JF
Gut; 2021 Jan; 70(1):170-179. PubMed ID: 32220902
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors in non-alcoholic fatty liver disease.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Askling J; Hultcrantz R; Kechagias S
Liver Int; 2019 Jan; 39(1):197-204. PubMed ID: 30253056
[TBL] [Abstract][Full Text] [Related]
6. Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease.
Masson S; Emmerson I; Henderson E; Fletcher EH; Burt AD; Day CP; Stewart SF
Liver Int; 2014 Feb; 34(2):235-42. PubMed ID: 23834275
[TBL] [Abstract][Full Text] [Related]
7. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.
Lackner C; Spindelboeck W; Haybaeck J; Douschan P; Rainer F; Terracciano L; Haas J; Berghold A; Bataller R; Stauber RE
J Hepatol; 2017 Mar; 66(3):610-618. PubMed ID: 27894795
[TBL] [Abstract][Full Text] [Related]
8. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study.
Moon JH; Jeong S; Jang H; Koo BK; Kim W
EClinicalMedicine; 2023 Nov; 65():102292. PubMed ID: 37954905
[TBL] [Abstract][Full Text] [Related]
9. Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost.
Chang WH; Mueller SH; Chung SC; Foster GR; Lai AG
J Transl Med; 2022 Jan; 20(1):2. PubMed ID: 34980174
[TBL] [Abstract][Full Text] [Related]
10. Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis.
Nasr P; Wester A; Ekstedt M; Strandberg R; Kechagias S; Shang Y; Widman L; Hagström H
Clin Gastroenterol Hepatol; 2024 May; 22(5):1048-1057.e2. PubMed ID: 38237695
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
Stevenson M; Lloyd-Jones M; Morgan MY; Wong R
Health Technol Assess; 2012; 16(4):1-174. PubMed ID: 22333291
[TBL] [Abstract][Full Text] [Related]
13. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
14. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
Aminian A; Al-Kurd A; Wilson R; Bena J; Fayazzadeh H; Singh T; Albaugh VL; Shariff FU; Rodriguez NA; Jin J; Brethauer SA; Dasarathy S; Alkhouri N; Schauer PR; McCullough AJ; Nissen SE
JAMA; 2021 Nov; 326(20):2031-2042. PubMed ID: 34762106
[TBL] [Abstract][Full Text] [Related]
15. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
Son JS; Choi S; Kim K; Kim SM; Choi D; Lee G; Jeong SM; Park SY; Kim YY; Yun JM; Park SM
JAMA; 2018 Nov; 320(17):1783-1792. PubMed ID: 30398603
[TBL] [Abstract][Full Text] [Related]
16. Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies.
Nagai S; Collins K; Chau LC; Safwan M; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2759-2768.e5. PubMed ID: 31004758
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
Simon TG; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
Gut; 2022 Sep; 71(9):1867-1875. PubMed ID: 34489307
[TBL] [Abstract][Full Text] [Related]
18. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
19. The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
Canney M; Gunning HM; Zheng Y; Rose C; Jauhal A; Hur SA; Sahota A; Reich HN; Barbour SJ
Am J Kidney Dis; 2022 Dec; 80(6):740-750. PubMed ID: 35659570
[TBL] [Abstract][Full Text] [Related]
20. Disentangling the contributions of alcohol use disorder and alcohol-related liver disease towards dementia: A population-based cohort study.
Zhao S; Widman L; Hagström H; Shang Y
Addiction; 2024 Apr; 119(4):706-716. PubMed ID: 38044804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
